Correlation Between Akero Therapeutics and Rhythm Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Rhythm Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Rhythm Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Rhythm Pharmaceuticals, you can compare the effects of market volatilities on Akero Therapeutics and Rhythm Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Rhythm Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Rhythm Pharmaceuticals.

Diversification Opportunities for Akero Therapeutics and Rhythm Pharmaceuticals

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Akero and Rhythm is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Rhythm Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rhythm Pharmaceuticals and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Rhythm Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rhythm Pharmaceuticals has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Rhythm Pharmaceuticals go up and down completely randomly.

Pair Corralation between Akero Therapeutics and Rhythm Pharmaceuticals

Given the investment horizon of 90 days Akero Therapeutics is expected to generate 2.24 times more return on investment than Rhythm Pharmaceuticals. However, Akero Therapeutics is 2.24 times more volatile than Rhythm Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Rhythm Pharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest  2,203  in Akero Therapeutics on November 9, 2024 and sell it today you would earn a total of  3,292  from holding Akero Therapeutics or generate 149.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Akero Therapeutics  vs.  Rhythm Pharmaceuticals

 Performance 
       Timeline  
Akero Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Rhythm Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Rhythm Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Akero Therapeutics and Rhythm Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akero Therapeutics and Rhythm Pharmaceuticals

The main advantage of trading using opposite Akero Therapeutics and Rhythm Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Rhythm Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rhythm Pharmaceuticals will offset losses from the drop in Rhythm Pharmaceuticals' long position.
The idea behind Akero Therapeutics and Rhythm Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio